Incidence and Outcomes of Cutaneous Angiosarcoma: a SEER Population Based Study.
Cutaneous angiosarcoma (CAS) is a rare, malignant tumor of vascular mesenchymal origin accounting for <1% of all sarcomas. To examine epidemiologic trends and outcomes in CAS. In this retrospective, population based study, patients with CAS were identified from the Surveillance Epidemiology and End Results database. Age, gender and race-standardized incidence rates(IR) were calculated. Survival was assessed using Kaplan-Meier curves and Cox proportional hazards models. Of 811 patients with CAS 43% had a prior primary cancer. CAS IR for patients without prior primary cancers dropped from 5.88 per 100,000 in 1973-1984 to 2.87 per 100,000 in 2005-2014. In those with prior primaries, IR rose from 0.03 per 100,000 in 1973-1984 to 2.25 per 100,000 in 2005-2014. On multivariate analysis, patients >70 years of age had a higher risk of death compared to those <50 (HR 2.16, 95%CI 1.33-3.57, p=0.002), and distant disease was associated with increased risk of death compared to localized disease (HR 1.50, 95%CI 1.11-2.03, p=0.008). Receipt of surgery and/or RT were not associated with survival. Potential selection and miscoding bias, retrospective nature. CAS rates are rising among those with other prior primary cancers. Survival is not impacted by current therapeutic strategies, highlighting the need for additional treatment options.